Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,533 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Management of chronic hepatitis C: consensus guidelines.
Sherman M, Shafran S, Burak K, Doucette K, Wong W, Girgrah N, Yoshida E, Renner E, Wong P, Deschênes M. Sherman M, et al. Can J Gastroenterol. 2007 Jun;21 Suppl C(Suppl C):25C-34C. Can J Gastroenterol. 2007. PMID: 17568824 Free PMC article.
Outcomes of chronic hepatitis C therapy in patients treated in community versus academic centres in Canada: final results of APPROACH (a prospective study of peginterferon alfa-2a and ribavirin at academic and community centres in Canada).
Myers RP, Cooper C, Sherman M, Lalonde R, Witt-Sullivan H, Elkashab M, Harris P, Balshaw R, Usaty C, Marrotta PJ. Myers RP, et al. Among authors: sherman m. Can J Gastroenterol. 2011 Sep;25(9):503-10. doi: 10.1155/2011/698780. Can J Gastroenterol. 2011. PMID: 21912762 Free PMC article.
Health state utilities and quality of life in patients with hepatitis B.
Woo G, Tomlinson G, Yim C, Lilly L, Therapondos G, Wong DK, Ungar WJ, Einarson TR, Sherman M, Heathcote JE, Krahn M. Woo G, et al. Among authors: sherman m. Can J Gastroenterol. 2012 Jul;26(7):445-51. doi: 10.1155/2012/736452. Can J Gastroenterol. 2012. PMID: 22803020 Free PMC article.
Management of chronic hepatitis B: consensus guidelines.
Sherman M, Shafran S, Burak K, Doucette K, Wong W, Girgrah N, Yoshida E, Renner E, Wong P, Deschênes M. Sherman M, et al. Can J Gastroenterol. 2007 Jun;21 Suppl C(Suppl C):5C-24C. Can J Gastroenterol. 2007. PMID: 17568823 Free PMC article.
Randomised clinical trial: the efficacy of treatment, guided by a shorter duration of response, using peginterferon alfa-2a plus ribavirin for hepatitis C virus other than genotypes 2 or 3.
Lee SS, Sherman M, Ramji A, Greenbloom S, Elkashab M, Pluta H, Hilzenrat N, Balshaw R, Usaty C, Myers RP. Lee SS, et al. Among authors: sherman m. Aliment Pharmacol Ther. 2012 Jan;35(1):37-47. doi: 10.1111/j.1365-2036.2011.04911.x. Epub 2011 Nov 2. Aliment Pharmacol Ther. 2012. PMID: 22050141 Free article. Clinical Trial.
Re-treatment with peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have relapsed or not responded to a first course of pegylated interferon-based therapy.
Yoshida EM, Sherman M, Bain VG, Cooper CL, Deschênes M, Marotta PJ, Lee SS, Krajden M, Witt-Sullivan H, Bailey RJ, Usaty C, Peltekian K; Pegasys Study Group. Yoshida EM, et al. Among authors: sherman m. Can J Gastroenterol. 2009 Mar;23(3):180-4. doi: 10.1155/2009/470532. Can J Gastroenterol. 2009. PMID: 19319382 Free PMC article.
2,533 results